Viewing StudyNCT00216671



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00216671
Status: COMPLETED
Last Update Posted: 2013-07-19
First Post: 2005-09-13

Brief Title: Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Sponsor: Janssen Pharmaceutica NV Belgium
Organization: Janssen Pharmaceutica NV Belgium

Conditions & Keywords Data

Conditions:
Name
Schizophrenia
Keywords:
Name View
long-acting risperidone View
Schizophrenia View
intramuscular injection View
antipsychotic agents View